NCT04924140 A Study to Assess Absolute Bioavailability of Aducanumab in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04895241 A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04870203 Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04856982 A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04832399 Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants Status COMPLETED Phase N/A
NCT04795206 Natural Disease Progression in Participants With Choroideremia Status COMPLETED Phase N/A
NCT04756700 Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple Sclerosis Status COMPLETED Phase NA
NCT04756687 Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera Status COMPLETED Phase N/A
NCT04729907 A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04702997 A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) Status COMPLETED Phase PHASE2
NCT04655222 Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program Status COMPLETED Phase N/A
NCT04599023 Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System Status TERMINATED Phase N/A
NCT04593121 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04580381 Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort Status COMPLETED Phase N/A
NCT04571424 A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB133 (Dapirolizumab Pegol) in Healthy Japanese and Caucasian Participants Status COMPLETED Phase PHASE1